Pyramid Labs
Jan Fuhr Miller currently serves as CFO at Pyramid Labs, a position held since January 2025. Prior to this role, Jan held the CFO position at CAPTEK® Softgel International from August 2023 to January 2025 and at PolyPeptide Group from September 2015 to August 2023. Jan's extensive finance career includes serving as Vice President of Finance at CMC Biologics and as District Finance Leader for Honeywell in the Nordics. Jan has held various finance leadership roles in Lundbeck entities in France, the USA, and Canada, in addition to earlier positions at H. Lundbeck A/S and Colgate-Palmolive A/S. Jan possesses an MBA in Finance from Keller Graduate School of Management of DeVry University and a Cand.Oecon. in Economics and Business Administration from Aarhus University, along with experience from an MBA exchange program at Cranfield School of Management.
This person is not in any teams
This person is not in any offices
Pyramid Labs
Founded in 1988, Pyramid Labs is a Drug Product CDMO specializing in injectable drug product development and manufacturing. Our capabilities include: • Clinical and Commercial Vial & Syringe Fill/Finish • Clinical and Commercial Lyophilization • Liquid Drug Product Formulation & Process Development • Lyophilized Drug Product Formulation & Cycle Development • PPQ and PV for late stage Drug Products • Labeling & Packaging • Quality Control Laboratory Services- In-process, Lot Release & Stability • Analytical Method Development & Validation • API & Drug Product Stability Studies